Skip to main content
OpenTrials

Clinical trial condition

Vaginal Atrophy

Explore clinical trials studying Vaginal Atrophy. Study availability and eligibility vary by location and protocol.

57 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Vaginal Atrophy trial results

Completed

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

NCT04574999

Conditions
Vaginal Atrophy
Locations
  • Hospital Sierrallana Torrelavega, Cantabria, Spain
  • Hospital Ruber Internacional Madrid, Castiglia, Spain
  • Centre Mèdic Teknon S.L. Barcelona, Catalonia, Spain
  • Fundació de Gestió Sanitària de l'Hospital de la Santa. Creu i Sant Pau Barcelona, Catalonia, Spain
View Trial Details
Completed

Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause

NCT03178825

Conditions
Chronic UTI, Dyspareunia, Female Urogenital Diseases, +12 more
Locations
  • Women's Pelvic Health Institute Los Gatos, California, United States
  • Coyle Institute Pensacola, Florida, United States
  • Louisiana State University New Orleans, Louisiana, United States
  • Carolinas Healthcare System Charlotte, North Carolina, United States
View Trial Details
Completed

Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

NCT02967510

Conditions
Vaginal Atrophy
Locations
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U Brno, Czechia
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. České Budějovice, Czechia
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. Olomouc, Czechia
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. Olomouc, Czechia
View all 23 locations
View Trial Details
Completed

A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting

NCT02413008

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. L'Hospitalet de Llobregat, Barcelona, Spain
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. A Coruña, Spain
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. Jaén, Spain
  • For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U. Madrid, Spain
View Trial Details

Related conditions